{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:13:45Z","timestamp":1791764025837,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008116","name":"Diabetes Research Center","doi-asserted-by":"publisher","award":["R21 EY035271"],"award-info":[{"award-number":["R21 EY035271"]}],"id":[{"id":"10.13039\/100008116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019340","name":"Wake Forest Clinical and Translational Science Institute, Wake Forest School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceutica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001420"],"award-info":[{"award-number":["UL1TR001420"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xops.2025.100909","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T02:56:19Z","timestamp":1754621779000},"page":"100909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pigmentary Maculopathy in Patients with Interstitial Cystitis: Association with Pentosan Polysulfate and Other Therapies"],"prefix":"10.1016","volume":"6","author":[{"given":"Sunny","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni K.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaewon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Havunjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieraj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Greven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3599-9021","authenticated-orcid":false,"given":"Sally S.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2025.100909_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0090-4295(97)00714-0","article-title":"Long-term experience with pentosanpolysulfate in interstitial cystitis","volume":"51","author":"Jepsen","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.xops.2025.100909_bib2","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100909_bib3","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jamaophthalmol.2020.2349","article-title":"Disease course in patients with pentosan polysulfate sodium\u2013associated maculopathy after drug cessation","volume":"138","author":"Shah","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2025.100909_bib4","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ophtha.2019.04.024","article-title":"Strength of association between pentosan polysulfate and a novel maculopathy","volume":"126","author":"Hanif","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100909_bib5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaophthalmol.2019.3392","article-title":"Phenotypic spectrum of pentosan polysulfate sodium\u2013associated maculopathy","volume":"137","author":"Hanif","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2025.100909_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcjo.2019.12.001","article-title":"Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100909_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ophtha.2020.01.017","article-title":"Prevalence of maculopathy associated with long-term pentosan polysulfate therapy","volume":"127","author":"Vora","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100909_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ajo.2023.05.021","article-title":"Progression of pentosan polysulfate sodium maculopathy in a prospective cohort","volume":"255","author":"Somisetty","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100909_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ajo.2022.07.015","article-title":"Pentosan polysulfate sodium-associated maculopathy: early detection using OCT angiography and choriocapillaris flow deficit analysis","volume":"244","author":"Fogel Levin","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100909_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.survophthal.2024.12.002","article-title":"Pentosan polysulfate sodium maculopathy: final analysis of a prospective cohort, updated review, and association with inflammatory bowel disease","volume":"70","author":"Santina","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.xops.2025.100909_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.oret.2021.07.004","article-title":"Expanded clinical spectrum of pentosan polysulfate maculopathy: a macula society collaborative study","volume":"6","author":"Jain","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2025.100909_bib12","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.oret.2020.05.008","article-title":"Pentosan polysulfate maculopathy versus inherited macular dystrophies","volume":"4","author":"Barnes","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2025.100909_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2021.02.025","article-title":"Pentosan polysulfate maculopathy: prevalence, spectrum of disease, and choroidal imaging analysis based on prospective screening","volume":"227","author":"Wang","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100909_bib14","first-page":"35","article-title":"An update on treatment options for interstitial cystitis","volume":"19","author":"Garzon","year":"2020","journal-title":"Prz Menopauzalny"},{"key":"10.1016\/j.xops.2025.100909_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3928\/23258160-20201223-04","article-title":"New insights into pentosan polysulfate maculopathy","volume":"52","author":"Abou-Jaoude","year":"2021","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.xops.2025.100909_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8866961","article-title":"Identification of patients with pentosan polysulfate sodium-associated maculopathy through screening of the electronic medical record at an academic center","volume":"2020","author":"Higgins","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100909_bib17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/bjophthalmol-2019-314765","article-title":"Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort","volume":"104","author":"Jain","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100909_bib18","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1111\/bcp.15303","article-title":"Risk of maculopathy with pentosan polysulfate sodium use","volume":"88","author":"Bae","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.xops.2025.100909_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ophtha.2019.10.013","article-title":"A novel multimethod image analysis to quantify pentosan polysulfate sodium retinal toxicity","volume":"127","author":"Hadad","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100909_bib20","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.2147\/OPTH.S340041","article-title":"Pentosan polysulfate sodium-associated pigmentary retinopathy: risk factors and fundus findings","volume":"15","author":"Leung","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.xops.2025.100909_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/09286586.2022.2031227","article-title":"Prevalence and dose dependency analysis of pentosan polysulfate sodium maculopathy","volume":"30","author":"Philip","year":"2023","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.xops.2025.100909_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.survophthal.2021.05.005","article-title":"Pentosan polysulfate maculopathy","volume":"67","author":"Lindeke-Myers","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.xops.2025.100909_bib23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/ICB.0000000000001090","article-title":"Potential new-onset clinically detectable pentosan polysulfate maculopathy years after drug cessation","volume":"16","author":"Barnett","year":"2022","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.xops.2025.100909_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cpt.597","article-title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update","volume":"102","author":"Hicks","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.xops.2025.100909_bib25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1006949816036","article-title":"Metabolism of tricyclic antidepressants","volume":"19","author":"Rudorfer","year":"1999","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.xops.2025.100909_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1743-7075-5-27","article-title":"Role of cytochrome P450 in drug interactions","volume":"5","author":"Bibi","year":"2008","journal-title":"Nutr Metab (Lond)"}],"updated-by":[{"DOI":"10.1016\/j.xops.2025.101002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000}}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525002076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525002076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T21:44:14Z","timestamp":1772919854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914525002076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666914525002076"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2025.100909","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pigmentary Maculopathy in Patients with Interstitial Cystitis: Association with Pentosan Polysulfate and Other Therapies","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2025.100909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100909"}}